5 active warrant series; nearest expiry 2034-03-10.
Compare this book against every issuer →5 option grants covering 3,900,000 shares (~8% potential dilution). Counted apart from the warrants above.
| Type | Status | Source | |||||
|---|---|---|---|---|---|---|---|
| option | $1.00 | Mar 10, 2034 2720d | 1.7M | OTM | 3.5% | $1.7M | Auto |
| option | $1.00 | Mar 31, 2035 3106d | 625K | OTM | 1.3% | $625K | Auto |
| option | $2.00 | Mar 31, 2035 3106d | 500K | OTM | 1.0% | $1.0M | Auto |
| option | $4.00 | Mar 31, 2035 3106d | 500K | OTM | 1.0% | $2.0M | Auto |
| option | $3.62 | Mar 25, 2036 3466d | 563K | OTM | 1.1% | $2.0M | Auto |
An issuer that discloses only a plan total appears as one line at its weighted-average exercise price and weighted-average remaining life — the filing's own summary, not a per-grant schedule.
49,026,477 shares outstanding, plus 0 from warrants and 3,900,000 from options — a fully diluted 52,926,477 shares, or ~8% above today's count if every one of them is exercised.
Price history with the company's supply walls overlaid — warrants (amber), employee and consultant options (pink), and free-trading unlock dates (violet). Each wall sits at the price the paper is struck at today, restated through any consolidation, and is measured in the SHARES it can issue rather than the number of certificates. Levels and dates are Pacific Time.
5 active warrant series; nearest expiry 2034-03-10.
Compare this book against every issuer →5 option grants covering 3,900,000 shares (~8% potential dilution). Counted apart from the warrants above.
| Type | Status | Source | |||||
|---|---|---|---|---|---|---|---|
| option | $1.00 | Mar 10, 2034 2720d | 1.7M | OTM | 3.5% | $1.7M | Auto |
| option | $1.00 | Mar 31, 2035 3106d | 625K | OTM | 1.3% | $625K | Auto |
| option | $2.00 | Mar 31, 2035 3106d | 500K | OTM | 1.0% | $1.0M | Auto |
| option | $4.00 | Mar 31, 2035 3106d | 500K | OTM | 1.0% | $2.0M | Auto |
| option | $3.62 | Mar 25, 2036 3466d | 563K | OTM | 1.1% | $2.0M | Auto |
An issuer that discloses only a plan total appears as one line at its weighted-average exercise price and weighted-average remaining life — the filing's own summary, not a per-grant schedule.
49,026,477 shares outstanding, plus 0 from warrants and 3,900,000 from options — a fully diluted 52,926,477 shares, or ~8% above today's count if every one of them is exercised.
Price history with the company's supply walls overlaid — warrants (amber), employee and consultant options (pink), and free-trading unlock dates (violet). Each wall sits at the price the paper is struck at today, restated through any consolidation, and is measured in the SHARES it can issue rather than the number of certificates. Levels and dates are Pacific Time.
